iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE)

Currency in USD
6.43
-0.13(-1.98%)
Closed·
Unusual trading volume
Day's Range
6.396.45
52 wk Range
5.237.20

Key Statistics

Morning Star Rating
Risk Rating
Bid / Ask
6.24 / 6.62
Prev. Close
6.56
Price Open
6.40
Volume
122,950
Average Vol. (3m)
35,330
1-Year Change
-5.05%
Day’s Range
6.39-6.45
52-Week Range
5.23-7.20
Market Cap
17.86B
Expense Ratio
0.35%
How do you feel today about BTEE?
Vote to see community's results!
or
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 10009849989341,1431,003-
Fund Return-1.63%-0.24%-6.57%+4.54%+0.05%-
Rank in Category63143568646-
Percentile Rank4070433733-
AMGN7.68%296.88+0.60%140,913
VRTX7.67%462.13+1.15%91,865
GILD7.62%113.18+0.79%368,902
REGN6.18%558.87+2.46%61,742

AstraZeneca PLC ADR

-4.48%--346,670
ALNY3.89%401.80+2.44%66,668

Summit Therapeutics Inc Ordinary Shares

-2.22%--435,909
BIIB2.01%131.95+3.09%86,005
INSM1.97%108.69+1.31%106,906

argenx SE ADR

-1.95%--18,515

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) Company Profile

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the biotechnology and pharmaceuticals sector. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the NASDAQ Biotechnology Index, by employing representative sampling methodology. iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF was formed on October 19, 2017 and is domiciled in Ireland.

Industry
-
Sector
-
0
Equity Type
ETF

FAQ

How is the performance of BTEE?

As of 02 Aug 2025, BTEE is trading at a price of 6.43, with a previous close of 6.56. The stock has fluctuated within a day range of 6.39 to 6.45, while its 52-week range spans from 5.23 to 7.20.

What is the current price of BTEE?

The BTEE stock price today is 6.43.

What is the P/E ratio of BTEE?

The P/E ratio for BTEE is 14.00.

From a Technical Analysis Perspective, Is BTEE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

What is the BTEE market cap?

The market cap for BTEE is 526.30M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.